arrow
S

Shozo Ohsumi

University of Tsukuba
H指数:34
被引数:3,942

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of exercise and educational programs on long-term quality of life, anxiety, and depression in breast cancer survivors: an exploratory secondary analysis of the Setouchi breast project-10 randomized controlled trial

运动和教育项目对乳腺癌幸存者长期生活质量、焦虑和抑郁的影响:Setouchi乳腺癌项目-10随机对照试验的探索性二次分析

2026-10-030
PRE
The effect of exercise and educational programs for breast cancer patients on the development of breast cancer-related lymphoedema: secondary endpoint from a randomized controlled trial in the Setouchi Breast Project-10
2024-07-091
PRE
Overall survival (OS) and subsequent therapy patterns in Japanese patients with HR+/HER2-advanced breast cancer (ABC) treated with palbociclib (PAL) plus letrozole (LET) in first-line setting (1L)
2024-05-020
PRE
Validation of a nuclear grading system for resected stage I-IIIA, high-risk, node-negative invasive breast carcinoma in the N•SAS-BC 01 trial

在N • sas-bc 01试验中,对切除的i-iiia期高风险,淋巴结阴性浸润性乳腺癌的核分级系统的验证

2022-04-182
OAAI
Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study (Aug, 10.1007/s12282-021-01283-4, 2021)
2021-09-251
OAAI
Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study
2021-08-314
OAAI
Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N•SAS-BC 01 trial and CUBC trial)
2020-12-011
OAAI
Prevalence of disease-causing genes in Japanese patients withBRCA1/2-wildtype hereditary breast and ovarian cancer syndrome
2020-06-1227
OAAI